calendar
1 catalysts · 21 phase 2 completion · 17 phase 1 completion · 9 phase 1 initiation · 9 phase 2 initiation · 5 phase 0 trial completion · 4 phase 3 initiation
next 91 dayslessmore
MonWedFri
1 catalysts · 21 phase 2 completion · 17 phase 1 completion · 9 phase 1 initiation · 9 phase 2 initiation · 5 phase 0 trial completion · 4 phase 3 initiation
Therapy area: Cardiovascular, Gastrointestinal. Indication: Endothelial Dysfunction, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD or NAFLD)